XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating activities:        
Net income (loss) $ (13,868) $ (13,853) $ (46,159) $ (64,899)
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation, Depletion and Amortization     8,301 11,843
Amortization of Financing Costs and Discounts     1,094 1,119
Share-based compensation     31,589 32,617
Provision for doubtful accounts     88 (371)
Loss on Disposition of Other Assets     51 0
Asset Impairment Charges 0 0 0 1,551
Gain (Loss) on Investments 0 3,308 0 3,308
Derivative, Loss on Derivative     4,343 0
Loss on Extinguishment of Debt 1,779 0 1,779 0
Changes in operating assets and liabilities:        
Accounts and unbilled receivables     (1,573) (4,900)
Increase (Decrease) in Deferred Costs     704 730
Prepaid expenses and other assets     31 (571)
Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net     (1,686) (1,925)
Accounts payable     (3,375) 2,911
Accrued liabilities     1,489 817
Accrued payroll and other employee benefits     (242) (7,388)
Deferred revenue     (401) 9,838
Net cash provided by (used in) operating activities     (3,967) (21,936)
Investing activities:        
Purchases of property and equipment     (2,168) (845)
Payments to Acquire Other Investments     (113) (169)
Net cash provided by (used in) investing activities     (2,281) (1,014)
Financing activities:        
Proceeds from Stock Plans 1,033 1,279 2,170 2,722
Tax withholding related to net share settlement of restricted stock units     (6,831) (212)
Payments of Debt Issuance Costs     (837) 0
Purchase of capped call     (22,771) 0
Net cash provided by (used in) financing activities     (28,269) 2,510
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations     (30) (289)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect     (34,547) (20,729)
Cash, cash equivalents and restricted cash:        
Beginning of period     203,627 227,553
End of period 169,080 206,824 169,080 206,824
Cash and cash equivalents 159,080 206,824 159,080 206,824
Restricted Cash, Noncurrent 10,000 0 10,000 0
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total $ 169,080 $ 206,824 169,080 206,824
Capital Expenditures Incurred but Not yet Paid     $ 236 $ 14